Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

After Tocagen Thaws IPO Freeze, Verona And Zymeworks Bring April Total To Three

Apr 29 2017

• By Mandy Jackson

trading

Related Content

UK's Verona £44.7m Capital Raising To Be Followed By NASDAQ Listing

Jun 20 2016

Finance Watch: Second Quarter Begins With Solid Base For Biopharma VC, Shaky Ground For Acorda

Apr 10 2017

Finance Watch: Raising Cash Before A Trump Slump, La Jolla Nabs $125m, Akcea Eyes $100m IPO

Mar 28 2017

Finance Watch: Two New VC Funds Raise $500m; One New US IPO; And Galena's 'Strategic Review'

Mar 17 2017

Takeda Targets Severe Epilepsies In Ovid Alliance

Jan 19 2017

Early Stage Biopharma Financings Kept Up Multibillion-Dollar Pace In 2016

Jan 05 2017

Ocular And UroGen Team-Up With Drug-Makers On Drug-Delivery Hydrogels

Oct 17 2016

Let's Make a Deal: Levin's Ovid Raises $75m

Aug 12 2015

US IPOs In Review: Relatively Muted Market In 2016 To Continue In 2017

Dec 31 2016

Venture Funding Deals: Innovent Sets Financing Record In China

Dec 15 2016

Pipeline Watch: Phase III Read-Outs For Ozanimod, Olaparib And Sapacitabine

Feb 27 2017

Tocagen Aims Double Barrels At Glioma

Feb 01 2017

IPO Update: Three Biopharma Offerings In January Contrast With Last Year’s Slow Start

Feb 06 2017

Related Companies

Tocagen, Inc.

Verona Pharma plc

Zymeworks, Inc.

BioMarin Pharmaceutical Inc.

Radius Health, Inc.

Novartis AG

Takeda Pharmaceutical Co. Ltd.

Ovid Therapeutics, Inc.

G1 Therapeutics Inc.

argenx N.V.

Biohaven Pharmaceutical Holding Company Ltd.

Teva Pharmaceutical Industries Ltd.

AnaptysBio, Inc.

Jounce Therapeutics, Inc.

ObsEva SA

BeyondSpring Inc.

Additional Topics

Financing Business Strategies Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.